Puramed Bioscience Inc. is currently trading at $1.50 per share, up $0.50 or 50%, on volume of about 50,000 shares. The stock, which hit a high of $1.99 earlier today, was mentioned about six months ago – April 2, 2009 – to be exact in the FREE Daily Newsletter from QualityStocks. At the time, Puramed Bioscience’s stock was trading for only 8 cents a share! For investors who jumped aboard at that time, they have seen their holding multiply by nearly 19 times!

Puramed Bioscience engages in the research, development and marketing of non-prescription products. The company’s leading product is LipiGesic M, which provides acute relief from migraine headaches. In addition, Puramed also has plans to launch LipiGesic PM, which provides a remedy for insomnia and other sleep disorders as well as LipiGesic H for common tension headaches.

If you are an investor interested in micro-cap and small-cap stocks, such as Puramed Bioscience, then the QualityStocks Newsletter is for you! At QualityStocks, we collate hundreds of smallcap newsletters into an easy-to-use summary format in which you can view the latest stock picks every day. Our members receive the “QualityStocks Daily” via email summarizing the latest coverage in the small-cap and micro-cap markets and providing you with a one-stop information resource. To receive the newsletter, visit www.signup.qualitystocks.net.